Yes, targeting methylation is a promising approach in disease treatment. Drugs known as demethylating agents can reverse aberrant methylation patterns. For example, 5-azacytidine and decitabine are used in the treatment of certain types of cancer. These agents work by inhibiting DNA methyltransferases, thereby reactivating silenced genes.
